Access to brain imaging rising in England – too slowly for optimum stroke care
This article was originally published in Clinica
Executive Summary
Emergency access to brain imaging for stroke patients is creeping up in England, but still barely one in three cases are scanned within one hour, and less than two-thirds of patients receive crucial clot-busting thrombolysis when potentially eligible, according to data published today by the Royal College of Physicians (RCP).
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.